Word: comfrey
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...underscored this year by the Consumers Union, publisher of Consumer Reports, which issued a "dirty dozen" list of supplements that have been linked to cancer, kidney or liver damage and heart problems and some of which have been banned in Europe and Asia. What to avoid: aristolochic acid, comfrey, androstenedione, chaparral, germander, kava, bitter orange, organ or gland extracts, lobelia, pennyroyal oil, scullcap and yohimbe. In addition, the FDA says, consumers should steer clear of supplements called Actra-Rx and Yilishen, which contain prescription-strength levels of sildenafil, the active ingredient in Viagra. It can lower blood pressure to dangerous...
...burden falls on the FDA to prove that supplements are not safe. The FDA last week got a prod when Consumers Union (CU) warned Americans that they should avoid a "dirty dozen" that may cause cancer, kidney or liver damage, even death. The list: aristolochic acid (birthwort), comfrey, germander, androstenedione, chaparral, kava, bitter orange, organ or gland extracts, lobelia, pennyroyal oil, scullcap and yohimbe...
...assume that "natural" means safe, unless you want to risk ending up like Socrates, who committed suicide by drinking hemlock. More recently, folks have suffered liver damage from sipping teas brewed from comfrey, an herb that is used in poultices and ointments to treat sprains and bruises and should never be taken internally. Special note to pregnant women and nursing mothers: you should avoid a number of herbs, including Echinacea, senna, comfrey and licorice...
Harvard is not the only one to bring in multiple counsel on this case. Renehan says he expects that Merrill Lynch attorney Kathleen Comfrey, a lawyer at New York's Sherman and Sterling, will be joined by a member of a Boston firm sometime in the next few weeks...
...accident was a heavy blow for Boulder-based Celestial, the largest U.S. maker of herb teas. Said Siegel: "It's been the worst week of my life." Nonetheless, the tempest-in-a-tea-stock is expected to blow over. The comfrey flavor represents a minute share of the Colorado company's total sales, which in fiscal 1983 increased by 26% to $27 million. The public offering will be rescheduled for early next year, when it is likely to bring Siegel a celestial cash windfall of more than $1 million...